{"schema_version":"secwatch.filing_event.v1","accession":"0001428336-23-000036","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.043938+00:00","generated_at":"2026-06-07T17:53:24.817698+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HealthEquity Q3 revenue $249M (+15% YoY); net income $14.7M; acquires BenefitWallet HSA portfolio for ~$425M","bullets":["Revenue $249.2M (+15% YoY); net income $14.7M vs net loss $1.6M prior year.","Non-GAAP net income $52.2M (+61%); adjusted EBITDA $95.6M (+30%), margin 38%.","HSAs 8.3M (+8%), total accounts 15.3M (+5%), HSA assets $22.6B (+12%).","Agreed to acquire BenefitWallet HSA portfolio for ~$425M plus $20M expenses; ~$2.8B assets in 665k accounts; close H1 FY2025.","FY2024 guidance: revenue $985-995M, adj. EBITDA $350-360M; FY2025 revenue ~$1.14-1.16B."],"urls":{"canonical":"https://secwatch.observer/filing/0001428336-23-000036","json":"https://secwatch.observer/filing/0001428336-23-000036.json","markdown":"https://secwatch.observer/filing/0001428336-23-000036.md","text":"https://secwatch.observer/filing/0001428336-23-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000036/0001428336-23-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000036/hqy-20231205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T17:53:24.817698+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b63aa59de70814777da4a1f61dab9c17d42c9a96","claim":"HEALTHEQUITY, INC. reported third quarter ended October 31, 2023 results: revenue $249.2 million, net income $14.7 million, EPS $0.17 per diluted share.","evidence_excerpt":"in such a filing. --- EX-99.1 (EX-99.1) --- HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results Highlights of the third quarter include: • Revenue of $249.2 million, an increase of 15% compared to $216.1 million in Q3 FY23. • Net income of $14.7 million, compared to net loss of $1.6 million in Q3 FY23, with non-GAAP net income of $52.2","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000036/0001428336-23-000036-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended October 31, 2023"},{"label":"Revenue","value":"$249.2 million"},{"label":"Net income","value":"$14.7 million"},{"label":"EPS","value":"$0.17 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}